Biologics (also known as Biopharmaceuticals) are one of the fastest growing segments of the pharmaceutical industry. In 2014, worldwide sales of biologicals was almost US$200 billion. In Europe, 7 out of 10 of the most sold medicines in 2014 were biological medicines.
Kumidas is proud of being able to offer a broad range of small molecules to meet your needs in biopharmaceutical synthesis. You can obtain all the necessary bridging tools for the most efficient synthesis related to this field. These small molecules are basically classified into the following groups: Coupling reagents, Protecting reagents, NAC (Nucleic Acid Chemistry) synthesis reagents, SPP Synthesis Linkers, Crosslinking reagents, Unnatural amino acids and their derivatives, Nucleotides & modified Nucleotides, Nucleosides & modified Nucleotides, PROTAC (PROteolysis TArgeting Chimera), Coenzymes and other small compounds.
Small molecules bridging to Biologics Overview
(Click each box for more information on individual product)
If you are unable to find a small molecule on the above limited displayed catalogue for your project linking to biologics (also known as biopharmaceuticals, biological medical products, biological drugs), we welcome your request by email to email@example.com, and will check the availability on our complete product list or otherwise use it to broaden our product range even further.
Please inquire for pricing and availability of listed products by writing email to firstname.lastname@example.org.